Miricor Enterprises Holdings (1827) Fundamentals 2026 — P/E 12.3x, Revenue Analysis | SniperIQ
Miricor Enterprises Holdings (1827) is a HK-listed Healthcare company in Medical - Care Facilities with a market capitalization of HK
Miricor Enterprises Holdings (1827) has a market capitalization of approximately HK
Miricor Enterprises Holdings's trailing twelve-month P/E ratio is 12.3x, with a price-to-book (P/B) of 2.3x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
Miricor Enterprises Holdings runs a net profit margin of 4.2%, a gross margin of 44.7%, and an operating margin of 17.2%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
Miricor Enterprises Holdings reported revenue of HK
Miricor Enterprises Holdings does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Miricor Enterprises Holdings carries a debt-to-equity ratio of 0.32x and a current ratio of 1.35x, with a market beta of 0.01. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Miricor Enterprises Holdings (1827) the key facts are: market cap HK
Get Miricor Enterprises Holdings's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.